NCT06067698View on ClinicalTrials.gov

Alpha Lipoic Acid in Ulcerative Colitis

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

April 1, 2025

Study Completion Date

April 1, 2025

Conditions
Ulcerative ColitisUlcerative Colitis (UC)
Interventions
DRUG

"Mesalamine and alpha-lipoic acid"

Mesalamine 1000 mg every 8 hrs. + alpha-lipoic acid 600 mg once daily for 3 months

DRUG

"Mesalamine and Placebo"

Mesalamine 1000 mg every 8 hrs. + Placebo once daily for 3 months

Trial Locations (1)

Unknown

RECRUITING

Tanat university hospital, Tanta

All Listed Sponsors
lead

Tanta University

OTHER